Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs

por Bossie, Cynthia A., Alphs, Larry D., Correll, Christoph U.
Publicado 2015

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia

por Turkoz, Ibrahim, Bossie, Cynthia A, Dirks, Bryan, Canuso, Carla M
Publicado 2008

Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD

por Pandina, Gahan J, Bossie, Cynthia A, Zhu, Young, Gharabawi, Georges M
Publicado 2007

Role of paliperidone extended-release in treatment of schizoaffective disorder

por Canuso, Carla M, Turkoz, Ibrahim, Fu, Dong Jing, Bossie, Cynthia A
Publicado 2010

Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent‐onset versus more chronic schizophrenia and a history of criminal justice sys...

por Alphs, Larry, Bossie, Cynthia, Mao, Lian, Lee, Erin, Starr, H. Lynn
Publicado 2015

Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder

por Bossie, Cynthia A., Turkoz, Ibrahim, Alphs, Larry, Mahalchick, Lucy, Fu, Dong-Jing
Publicado 2017

Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis

por Turkoz, Ibrahim, Bossie, Cynthia A, Lindenmayer, Jean-Pierre, Schooler, Nina, Canuso, Carla M
Publicado 2011

Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, dou...

por Alphs, Larry, Bossie, Cynthia A, Sliwa, Jennifer K, Ma, Yi-Wen, Turner, Norris
Publicado 2011

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia

por Sliwa, Jennifer Kern, Bossie, Cynthia A, Fu, Dong-Jing, Turkoz, Ibrahim, Alphs, Larry
Publicado 2012

Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate

por Sliwa, Jennifer Kern, Fu, Dong-Jing, Bossie, Cynthia A, Turkoz, Ibrahim, Alphs, Larry
Publicado 2014

Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial

por Bossie, Cynthia A, Sliwa, Jennifer K, Ma, Yi-Wen, Fu, Dong-Jing, Alphs, Larry
Publicado 2011

Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial

por Bossie, Cynthia A., Fu, Dong-Jing, Sliwa, Jennifer Kern, Alphs, Larry, Ma, Yi-Wen
Publicado 2011

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics

por Alphs, Larry, Bossie, Cynthia A, Sliwa, Jennifer Kern, Fu, Dong-Jing, Ma, Yi-Wen, Hulihan, Joseph
Publicado 2013

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial

por Gharabawi, Georges M, Greenspan, Andrew, Rupnow, Marcia FT, Kosik-Gonzalez, Colette, Bossie, Cynthia A, Zhu, Young, Kalali, Amir H, Awad, A George
Publicado 2006

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended...

por Gharabawi, Georges M, Gearhart, Natalie C, Lasser, Robert A, Mahmoud, Ramy A, Zhu, Young, Mannaert, Erik, Naessens, Ineke, Bossie, Cynthia A, Kujawa, Mary, Simpson, George M
Publicado 2007